18.05.2012 Views

Q3 2010 Analyst Presentation

Q3 2010 Analyst Presentation

Q3 2010 Analyst Presentation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Nine Months / Third Quarter <strong>2010</strong> Results<br />

03 November <strong>2010</strong>


Agenda<br />

Highlights and key figures first nine months<br />

Financial results third quarter<br />

Business review<br />

Outlook<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 2 / 55


Highlights and key figures first nine<br />

months<br />

Success of the restructuring program leveraged by the favorable and robust economic<br />

environment in the first nine months:<br />

– Local currency sales grew 14% year-on-year<br />

– Gross profit margin improved to 28.5% from 23.1% in 9M 2009<br />

– EBIT before exceptionals rose 253% to CHF 576 million from CHF 163 million<br />

– EBIT margin before exceptionals at 10.6% vs. 3.3%<br />

– Net income CHF 144 million compared to net loss CHF 127 million<br />

Sales price increases fully compensated for higher raw material costs at the end of the period<br />

– Focus on further selective sales price increases where necessary<br />

Final decisions to optimize production footprint within the Global Network Optimization<br />

Program (GANO) taken in October<br />

– Savings of at least CHF 100 million annually by 2013 expected<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Highlights and key figures first nine months<br />

Slide 3 / 55


Agenda<br />

Highlights and financial results nine months<br />

Financial results third quarter<br />

Business review<br />

Outlook<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 4 / 55


Key figures third quarter<br />

Sales in CHF mn 1 709 1 691<br />

Gross margin* 27.9% 25.3%<br />

EBIT before exceptionals in CHF mn 28.7% 182 29.2% 107<br />

EBIT margin before exceptionals 10.6% 6.3%<br />

Net income in CHF mn 109** 25<br />

Operating cash flow in CHF mn 173 193<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong>/10 <strong>Q3</strong>/09 in CHF in LC<br />

* restated gross margin includes freight costs as of 1 January <strong>2010</strong> / reported gross margin in <strong>Q3</strong> 2009 was 30.1%<br />

** includes a one-time benefit from the capitalization of tax assets of CHF 45 mn<br />

+1%<br />

Financial results third quarter<br />

+8%<br />

Slide 5 / 55


Single- to double-digit sales growth in all<br />

regions despite more challenging base<br />

Sales growth in local currencies<br />

Sales mix:<br />

– Volume +5%<br />

– Price +3%<br />

– Acq./div. 0%<br />

– Currency –7%<br />

Single-digit to double-digit sales growth in<br />

local currency in all regions<br />

Significant currency impact on top-line<br />

growth due to Swiss franc appreciation<br />

Close to 50% of sales generated in the<br />

emerging markets of Asia, Latam, MEA<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong>/10<br />

+8%<br />

Total sales <strong>Q3</strong>/10: CHF 1 709 mn<br />

incl. China<br />

105 / +5%<br />

+6%<br />

+9%<br />

incl. Brazil<br />

149 / 0%<br />

+11%<br />

Sales growth in local currencies<br />

<strong>Q3</strong>/09<br />

–14%<br />

Financial results third quarter<br />

incl. Germany<br />

223 / +13%<br />

Asia/<br />

Pacific<br />

383 Europe, Middle<br />

Latin<br />

America<br />

308<br />

North<br />

America<br />

216<br />

East & Africa<br />

802<br />

+9%<br />

Middle East & Africa<br />

135 / +9%<br />

Slide 6 / 55


Gross margin management successful<br />

Gross margin significantly higher versus year-ago<br />

period<br />

Gross margin remained close to first half-year<br />

level despite seasonally higher idle facility costs<br />

Sales price increases of 1% fully offset rising raw<br />

material costs of less than 2% sequentially<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong>/10 <strong>Q3</strong>/09*<br />

Gross margin 27.9% 25.3%<br />

* restated gross margin includes freight costs as of 1 January <strong>2010</strong> / reported gross margin in <strong>Q3</strong> 2009 was 30.1%<br />

Financial results third quarter<br />

sales price increases<br />

RM cost increases (sales-weighted)<br />

2008 2009 <strong>2010</strong><br />

Slide 7 / 55


Operating margin before exceptionals<br />

rises on lower SG&A costs<br />

EBIT before exceptionals in CHF mn 182 107<br />

EBIT margin before exceptionals 10.6% 6.3%<br />

Operating income before exceptionals items up 70% compared to the same quarter<br />

of the previous year<br />

Operating income before exceptionals margin at the level of H1 <strong>2010</strong> despite the<br />

normal seasonal pattern in demand and seasonally higher idle facility costs<br />

SG&A costs lower in absolute numbers due to restructuring benefits and a favorable<br />

FX impact<br />

SG&A costs in percent of sales down to 15.6% in <strong>Q3</strong> <strong>2010</strong> from 17.3% in <strong>Q3</strong> 2009<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong>/10<br />

<strong>Q3</strong>/09<br />

Financial results third quarter<br />

Slide 8 / 55


Solid cash flow generation driven by<br />

operating result<br />

Operating cash flow in CHF mn<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong>/10<br />

Cash flow before changes in working capital rose to CHF 116 million in <strong>Q3</strong> <strong>2010</strong><br />

compared to CHF 78 million in <strong>Q3</strong> 2009 as operating income improved<br />

Cash flow also driven by lower impact from inventories build-up compared to H1 <strong>2010</strong><br />

and continuation of strict net working capital management<br />

NWC in % of sales down to 19.7% as of end <strong>Q3</strong> <strong>2010</strong> from 23.2% as of <strong>Q3</strong> 2009<br />

Restructuring and impairment costs of CHF 45 million, cash-out CHF 37 million<br />

Ramp-up of capex to CHF 55 million vs. CHF 26 million in the year-ago period, driven<br />

by investments in China and relocation of production within the context of GANO<br />

173<br />

<strong>Q3</strong>/09<br />

193<br />

Financial results third quarter<br />

Slide 9 / 55


Financial result – net debt further reduced<br />

Financial result in CHF mn<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong>/10<br />

Financial result nearly flat at CHF –27 million versus CHF –28 million in <strong>Q3</strong> 2009, as<br />

lower financial and interest expenses more than offset the negative currency result<br />

Slightly lower interest expenses of CHF –19 million vs. CHF –21 million in <strong>Q3</strong> 2009<br />

Cash and cash equivalents – including short-term deposits of CHF 643 million –<br />

improved to CHF 1 272 million from CHF 1 140 million at year-end 2009 and<br />

CHF 1 221 million at end Q2 <strong>2010</strong><br />

Net debt down to CHF 302 million from CHF 545 million at year-end 2009 and<br />

CHF 379 million at the end of Q2 <strong>2010</strong><br />

Gearing improved to 16% from 29% at year-end 2009 and from 20% at end Q2 <strong>2010</strong><br />

–27<br />

<strong>Q3</strong>/09<br />

–28<br />

Financial results third quarter<br />

Slide 10 / 55


Agenda<br />

Highlights and financial results nine months<br />

Financial results third quarter<br />

Business review<br />

Outlook<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 11 / 55


Business unit sales, EBITDA and EBIT<br />

margins<br />

Third quarter <strong>2010</strong><br />

Business Unit / Reporting Segment:<br />

BU Industrial & Consumer Specialties<br />

BU Masterbatches<br />

BU Pigments<br />

BU Textile Chemicals<br />

BU Oil & Mining Services<br />

BU Leather Services<br />

Performance Chemicals*<br />

Group total<br />

Sales<br />

CHF mn<br />

341<br />

315<br />

301<br />

199<br />

142<br />

1 709<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

76<br />

335<br />

% CHF<br />

–2<br />

3<br />

6<br />

–1<br />

4<br />

1<br />

–2<br />

1<br />

Change<br />

% LC<br />

* includes the four business units Additives, Detergents & Intermediates, Emulsions, Paper Specialties<br />

** before exceptional items<br />

9<br />

11<br />

11<br />

3<br />

10<br />

5<br />

6<br />

8<br />

EBITDA**<br />

margin<br />

%<br />

15.8<br />

12.4<br />

21.9<br />

9.5<br />

11.3<br />

13.2<br />

13.1<br />

13.6<br />

Business review<br />

EBIT**<br />

margin<br />

%<br />

13.5<br />

10.2<br />

19.3<br />

6.0<br />

11.3<br />

11.8<br />

10.1<br />

10.6<br />

Slide 12 / 55


ICS with improved margins, favorable<br />

demand situation in Masterbatches<br />

Industrial & Consumer Specialties<br />

Sales in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

341<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

315<br />

Change<br />

(LC)<br />

Masterbatches<br />

Sales in CHF mn<br />

<strong>Q3</strong><br />

2009<br />

46<br />

+9% 348<br />

+93%<br />

13.5%<br />

Change<br />

(LC)<br />

<strong>Q3</strong><br />

2009<br />

Good demand across the whole portfolio<br />

32<br />

+11% 305<br />

+22%<br />

10.2%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Demand driven by the Industrial Applications segment:<br />

construction, paints & coatings, lubricants<br />

Agrochemicals continued to recover in-line with market,<br />

demand in Consumer Care segment remained high<br />

Demand from all end markets including automotive,<br />

packaging, and textiles remained at good levels<br />

Impact from replenishment of inventories in some end<br />

markets softened<br />

Further optimization of production network initiated<br />

Business review<br />

EBIT before exc. in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

Change<br />

(LC)<br />

<strong>Q3</strong><br />

2009<br />

27<br />

7.8%<br />

EBIT before exc. in CHF mn<br />

<strong>Q3</strong><br />

2009<br />

28<br />

9.2%<br />

Slide 13 / 55


Pigments with excellent performance,<br />

Textile Chemicals with good growth in Asia<br />

Pigments<br />

Sales in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

301<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

199<br />

Change<br />

(LC)<br />

Textile Chemicals<br />

Sales in CHF mn<br />

<strong>Q3</strong><br />

2009<br />

58<br />

+11% 284<br />

+115%<br />

19.3%<br />

Change<br />

(LC)<br />

<strong>Q3</strong><br />

2009<br />

No sign of weakness in demand<br />

12<br />

+3% 200<br />

+47%<br />

6.0%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Coatings: demand from decorative segment and from<br />

automotive industry remained strong<br />

Printing: good demand for pigments used in packaging<br />

inks and in non-impact printing applications<br />

Demand from the textile industry remained solid<br />

Relocation of BU headquarters to Singapore mid 2011<br />

Transfer of production to Asia proceeding well:<br />

production started in other plants, inventories build-up<br />

to guarantee supply during transition phase<br />

Business review<br />

EBIT before exc. in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

Change<br />

(LC)<br />

<strong>Q3</strong><br />

2009<br />

28<br />

9.9%<br />

EBIT before exc. in CHF mn<br />

<strong>Q3</strong><br />

2009<br />

8<br />

4.0%<br />

Slide 14 / 55


OMS strengthened market position, Leather<br />

Services benefited from luxury car boom<br />

Oil & Mining Services<br />

Sales in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

142<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

76<br />

Change<br />

(LC)<br />

Leather Services<br />

Sales in CHF mn<br />

<strong>Q3</strong><br />

2009<br />

16<br />

+10% 136<br />

–6%<br />

11.3%<br />

Change<br />

(LC)<br />

<strong>Q3</strong><br />

2009<br />

Strength in global oil drilling activity<br />

9<br />

+5% 75<br />

+56%<br />

11.8%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Mining Services: upward trend continuing, but at<br />

a slower pace than in H1 <strong>2010</strong><br />

BU further strengthened market positions in the Middle<br />

East and in Latin America<br />

Continuing good demand from the premium car<br />

segment<br />

More moderate growth in the upholstery and shoe<br />

segment<br />

Market share gains in Latin America<br />

Business review<br />

EBIT before exc. in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

Change<br />

(LC)<br />

<strong>Q3</strong><br />

2009<br />

16<br />

11.8%<br />

EBIT before exc. in CHF mn<br />

<strong>Q3</strong><br />

2009<br />

6<br />

8.0%<br />

Slide 15 / 55


Performance Chemicals – increased sales<br />

prices offset higher raw material costs<br />

Performance Chemicals*<br />

Sales in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

335<br />

* the Performance Chemicals segment includes the business units:<br />

- Additives<br />

Change<br />

(LC)<br />

- Detergents & Intermediates<br />

- Emulsions<br />

- Paper Specialties<br />

<strong>Q3</strong><br />

2009<br />

34<br />

+6% 343 demand for paper chemicals and dyes stable<br />

+49%<br />

10.1%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Additives: continued good demand in all businesses<br />

D&I: good demand and high capacity utilization<br />

Emulsion: flat sales in lc versus year-ago quarter<br />

Business review<br />

EBIT before exc. in CHF mn<br />

<strong>Q3</strong><br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

<strong>Q3</strong><br />

2009<br />

26<br />

7.6%<br />

Slide 16 / 55


Agenda<br />

Highlights and financial results nine months<br />

Financial results third quarter<br />

Business review<br />

Outlook<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 17 / 55


Our roadmap – restructuring program<br />

completed in <strong>2010</strong>, ready to shift our focus<br />

Timeline<br />

Focus<br />

Actions<br />

< 2009 > <strong>2010</strong><br />

Restructuring<br />

Project Clariant<br />

Cash generation<br />

Cost cutting<br />

Complexity<br />

reduction<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Continuous improvement<br />

Clariant Excellence<br />

People Excellence<br />

Operational Excellence<br />

Commercial Excellence<br />

Profitable growth<br />

Growth & Opportunities<br />

Innovation Excellence<br />

Portfolio management<br />

Outlook<br />

Slide 18 / 55


Making progress to achieve our full-year<br />

<strong>2010</strong> targets<br />

11%<br />

10%<br />

9%<br />

8%<br />

7%<br />

6%<br />

5%<br />

4%<br />

Operating margin<br />

before exceptionals<br />

6.3%<br />

10.6%<br />

<strong>Q3</strong> 2009 <strong>Q3</strong> <strong>2010</strong><br />

EBIT before exceptional<br />

items above 9%<br />

18.0%<br />

17.5%<br />

17.0%<br />

16.5%<br />

16.0%<br />

15.5%<br />

15.0%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

SG&A in % of sales<br />

17.3%<br />

15.6%<br />

<strong>Q3</strong> 2009 <strong>Q3</strong> <strong>2010</strong><br />

SG&A costs in-line with<br />

peer group companies<br />

24%<br />

23%<br />

22%<br />

21%<br />

20%<br />

19%<br />

18%<br />

Outlook<br />

NWC in % of sales<br />

23.2%<br />

19.7%<br />

<strong>Q3</strong> 2009 <strong>Q3</strong> <strong>2010</strong><br />

Net working capital down<br />

to 19.7%, FY target of 20%<br />

Slide 19 / 55


GANO project finalized – execution<br />

until 2013<br />

Business Unit<br />

Industrial & Consumer<br />

Specialties<br />

Masterbatches<br />

Paper Specialties<br />

Pigments<br />

Textile Chemicals<br />

FTE reduction<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Pontypridd (UK)<br />

CIVAC (MX)<br />

Muttenz (CH)<br />

Muttenz (CH)<br />

approx. 1 100 – 1 200<br />

Estimated GANO-related impact on P&L and Cash-flow statement <strong>2010</strong>-2013:<br />

P&L effect (Restr. & Imp.)<br />

Cash–out (excl. capex)<br />

Site closure<br />

Plant / production line closure<br />

Lachine (CA)<br />

Milford (US)<br />

Guatemala City<br />

site consolidation<br />

Resende (BR)<br />

Thane (IN)<br />

Onsan (KR)<br />

<strong>2010</strong> – 2013<br />

Gendorf (DE)<br />

Sefakoy (TR)<br />

Delta (CA)<br />

McHenry (US)<br />

Huningue (FR)<br />

Hoechst (DE)<br />

Tianjin (CN)<br />

Huningue (FR)<br />

Roha (IN)<br />

Shizuoka (JP)<br />

2009/10: ~ CHF 290 mn 2011–13: < CHF 100 mn<br />

2009/10: ~ CHF 50 mn 2011–13: ~ CHF 180 mn<br />

→ Total net annual savings realized after 2013: ≥ CHF 100 million<br />

→ Nanterre (FR): move of France headquarters to Lamotte (FR)<br />

Outlook<br />

Reinach (CH)<br />

Reinach (CH)<br />

Slide 20 / 55


Outlook – business conditions for the<br />

fourth quarter<br />

Environment<br />

For the remainder of the year, Clariant expects stable trading conditions<br />

Clariant expects a return to normal seasonality, with a traditionally weaker<br />

fourth quarter<br />

Raw material costs are expected to rise further but at a slower pace than in<br />

the first nine months of the year<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Outlook<br />

Slide 21 / 55


Outlook – Clariant<br />

Ongoing restructuring program will be finalized by the end of <strong>2010</strong>, company will<br />

then be managed for profitable growth as of 2011<br />

Some of the measures – in particular related to the GANO activities – will not be<br />

completely implemented before 2013<br />

<strong>2010</strong> guidance:<br />

High single-digit sales growth in local currency compared to 2009<br />

Operating income margin before exceptional items above 9%, raised from above 8%<br />

Operating cash flow will remain strong<br />

Return on invested capital (ROIC) above industry average by the end of <strong>2010</strong><br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Outlook<br />

Slide 22 / 55


Calendar of upcoming corporate events<br />

16 February 2011 Full-year Results <strong>2010</strong><br />

31 March 2011 Annual General Meeting, Basel<br />

02 May 2011 First Quarter Results 2011<br />

27 July 2011 Second Quarter Results 2011<br />

31 October 2011 Third Quarter Results 2011<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 23 / 55


IR contacts<br />

Dr. Ulrich Steiner<br />

Head Investor Relations<br />

Phone +41 (0) 61 469 67 45<br />

Mobile +41 (0) 79 297 27 07<br />

email ulrich.steiner@clariant.com<br />

Dr. Siegfried Schwirzer<br />

Investor Relations Officer<br />

Phone +41 (0) 61 469 67 49<br />

Mobile +41 (0) 79 718 45 98<br />

email siegfried.schwirzer@clariant.com<br />

Edith Schwab<br />

Phone +41 (0) 61 469 67 48<br />

Fax +41 (0) 61 469 67 67<br />

email edith.schwab@clariant.com<br />

Mirjam Grieder<br />

Phone +41 (0) 61 469 67 66<br />

Fax +41 (0) 61 469 67 67<br />

email mirjam.grieder@clariant.com<br />

Clariant International Ltd Hardstrasse 61 4133 Pratteln Switzerland investor-relations@clariant.com<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 24 / 55


Backup Slides –<br />

Nine Months / Third Quarter <strong>2010</strong> Results<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 25 / 55


Clariant’s products and services are<br />

delivered through 10 Business Units (1)<br />

Additives<br />

A leading provider of<br />

flame retardants,<br />

waxes and polymer<br />

additives<br />

for effects in plastics,<br />

coatings and other<br />

applications.<br />

Detergents &<br />

Intermediates<br />

A leading supplier of<br />

key raw materials and<br />

intermediates to the<br />

detergents, agro and<br />

pharmaceutical<br />

industries.<br />

Emulsions<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

A supplier of waterbased<br />

emulsions/polymer<br />

dispersions for paints,<br />

coatings, adhesives,<br />

construction, sealants<br />

and for the textile,<br />

leather and paper<br />

industries.<br />

Industrial &<br />

Consumer Specialties<br />

A leading provider of<br />

specialty chemicals and<br />

application solutions<br />

for the consumer care<br />

and industrial markets.<br />

Backup slides<br />

Leather Services<br />

A leading supplier of<br />

chemicals and services<br />

to the leather industry.<br />

Slide 26 / 55


Clariant’s products and services are<br />

delivered through 10 Business Units (2)<br />

Masterbatches<br />

A leader in coloration<br />

and functionality of<br />

plastics, supplying the<br />

packaging, consumer<br />

goods, medical, textile<br />

and automotive<br />

sectors.<br />

Oil & Mining<br />

Services<br />

A leading provider of<br />

products and services<br />

to the oil, refinery and<br />

mining industries.<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Paper Specialties<br />

A leading provider of<br />

optical brighteners,<br />

colorants and<br />

functional chemicals<br />

for paper and<br />

packaging applications.<br />

Pigments<br />

A leading global<br />

provider of organic<br />

pigments and dyes for<br />

coatings,paints,<br />

printing, plastics and<br />

special applications.<br />

Backup slides<br />

Textile Chemicals<br />

A leading producer of<br />

dyes and chemicals for<br />

the textile industry<br />

including apparel,<br />

upholstery, fabrics and<br />

carpets.<br />

Slide 27 / 55


Peer group ROIC<br />

Measuring performance<br />

based on relative ROIC*<br />

Ems-Chemie<br />

Lubrizol<br />

Croda<br />

PolyOne<br />

Rhodia<br />

Nalco<br />

BASF<br />

Akzo Nobel<br />

Albemarle<br />

Evonik<br />

Kemira<br />

CLARIANT<br />

Dow Chemical<br />

DSM<br />

Lanxess<br />

Celanese<br />

Rockwood<br />

Solvay<br />

Cytec<br />

Wacker<br />

Huntsman<br />

Arkema<br />

Mitsubishi Chemical<br />

0.1<br />

1.0<br />

0.9<br />

2.1<br />

2.1<br />

2.6<br />

* source: calculated from annual reports<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

3.7<br />

4.2<br />

4.1<br />

2009 average<br />

6.6%<br />

5.0<br />

5.7<br />

5.5<br />

5.8<br />

6.2<br />

7.3<br />

7.1<br />

7.6<br />

7.5<br />

9.6<br />

11.5<br />

0 5 10 15 20 25<br />

12.9<br />

18.5<br />

Backup slides<br />

20.8<br />

Slide 28 / 55


Restated group gross profit and<br />

SG&A 2009<br />

Starting 1 January <strong>2010</strong>, Clariant reports freight costs as included in the costs of goods<br />

sold line (before: in selling, general & administrative costs)<br />

This change affects line items as follows:<br />

Lower gross profit and gross profit margin<br />

Lower absolute selling, general & administrative costs and lower SG&A costs in<br />

percentage of sales<br />

All other figures remain unchanged.<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Backup slides<br />

Slide 29 / 55


Restated group gross profit 2009<br />

Group gross profit margin 2009 & <strong>2010</strong> – in CHF mn<br />

Gross profit reported<br />

- margin<br />

Gross profit restated<br />

- margin<br />

Quarterly figures<br />

600<br />

400<br />

200<br />

0<br />

379<br />

303<br />

471<br />

399<br />

Q1<br />

379<br />

23.6%<br />

303<br />

18.9%<br />

Q2<br />

471<br />

29.3%<br />

399<br />

24.8%<br />

509 506<br />

428 427<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong><br />

509<br />

30.1%<br />

428<br />

25.3%<br />

Q4<br />

506<br />

29.6%<br />

427<br />

25.0%<br />

FY/09<br />

1 865<br />

28.2%<br />

1 557<br />

23.5%<br />

Q1/10<br />

–<br />

–<br />

521<br />

28.7%<br />

Q1 2009 Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

reported restated margin reported / in % of sales reported margin restated / in % of sales restated<br />

n/a<br />

521<br />

n/a<br />

547<br />

Backup slides<br />

n/a<br />

477<br />

Q2/10<br />

–<br />

–<br />

547<br />

28.9%<br />

<strong>Q3</strong>/10<br />

–<br />

–<br />

477<br />

27.9%<br />

Slide 30 / 55


Restated group SG&A 2009<br />

Group SG&A costs 2009 & <strong>2010</strong> – in CHF mn<br />

SG&A costs reported<br />

- in % of sales<br />

SG&A costs restated<br />

- in % of sales<br />

Quarterly figures<br />

400<br />

300<br />

200<br />

100<br />

0<br />

reported restated<br />

Q1<br />

357<br />

22.2<br />

281<br />

17.5<br />

Q2<br />

371<br />

23.1<br />

299<br />

18.6<br />

357 371 373 369<br />

281<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>Q3</strong><br />

373<br />

22.0<br />

292<br />

17.3<br />

369<br />

21.6<br />

290<br />

17.0<br />

FY/09<br />

1 470<br />

22.2<br />

1 162<br />

17.6<br />

299 292 290 307 309<br />

Q1/10<br />

Q1 2009 Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

–<br />

–<br />

307<br />

16.9<br />

margin reported / in % of sales reported margin restated / in % of sales restated<br />

n/a<br />

Q4<br />

n/a<br />

Backup slides<br />

n/a<br />

267<br />

Q2/10<br />

–<br />

–<br />

309<br />

16.3<br />

<strong>Q3</strong>/10<br />

–<br />

–<br />

267<br />

15.6<br />

Slide 31 / 55


Key financials – nine months<br />

Nine months<br />

Sales<br />

Local currency growth (LC)<br />

- Organic growth rate*<br />

- Acquisitions/Divestments<br />

Currencies<br />

Gross profit**<br />

EBITDA before exceptionals<br />

EBITDA<br />

Operating income before exceptionals<br />

Operating income<br />

Net income / loss<br />

Operating cash flow<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

CHF mn<br />

5 420<br />

14%<br />

14%<br />

0%<br />

–3%<br />

1 545<br />

731<br />

541<br />

576<br />

335<br />

144<br />

365<br />

<strong>2010</strong><br />

% of sales<br />

100%<br />

28.5%<br />

13.5%<br />

10.0%<br />

10.6%<br />

6.2%<br />

2.7%<br />

CHF mn<br />

4 904<br />

1 130<br />

331<br />

–127<br />

533<br />

2009<br />

% of sales<br />

* organic growth: volume and price effects excluding the impact of changes in foreign currency exchange rates and acquisitions/divestments<br />

** gross profit includes freight costs as of first quarter <strong>2010</strong>. Reported gross profit in 9M 2009 was CHF 1 359 million, gross margin 27.7%<br />

206<br />

163<br />

3<br />

Backup slides<br />

100%<br />

23.1%<br />

6.7%<br />

4.2%<br />

3.3%<br />

0.1%<br />

2.6%<br />

Slide 32 / 55


Sales – nine months<br />

Sales growth in local currencies<br />

Sales mix:<br />

– Volume 14%<br />

– Price 0%<br />

– Acq./div. 0%<br />

– Currency –3%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

9M/10<br />

+14%<br />

Total sales 9M/10: CHF 5 420 mn<br />

+17%<br />

+12%<br />

incl. Brazil<br />

446 / +3%<br />

incl. China<br />

321 / +28%<br />

Sales growth in local currencies<br />

Backup slides<br />

9M/09<br />

–18%<br />

incl. Germany<br />

738 / +22%<br />

Asia/<br />

Pacific<br />

1 154 Europe, Middle<br />

Latin<br />

America<br />

920<br />

North<br />

America<br />

669<br />

+14%<br />

East & Africa<br />

2 677<br />

+15%<br />

Middle East & Africa<br />

426 / +15%<br />

Slide 33 / 55


Business unit sales, EBITDA and EBIT<br />

margins – nine months<br />

Nine months <strong>2010</strong><br />

Business Unit / Reporting Segment:<br />

BU Industrial & Consumer Specialties<br />

BU Masterbatches<br />

BU Pigments<br />

BU Textile Chemicals<br />

BU Oil & Mining Services<br />

BU Leather Services<br />

Performance Chemicals*<br />

Group total<br />

Sales<br />

CHF mn<br />

1 128<br />

981<br />

907<br />

634<br />

438<br />

251<br />

1 081<br />

5 420<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

% CHF<br />

7<br />

17<br />

14<br />

10<br />

4<br />

27<br />

7<br />

11<br />

Change<br />

% LC<br />

* includes the four business units Additives, Detergents & Intermediates, Emulsions, Paper Specialties<br />

** before exceptional items<br />

14<br />

21<br />

17<br />

11<br />

5<br />

30<br />

11<br />

14<br />

EBITDA**<br />

margin<br />

16.5<br />

12.7<br />

21.7<br />

9.6<br />

12.1<br />

13.5<br />

14.8<br />

13.5<br />

Backup slides<br />

%<br />

EBIT**<br />

margin<br />

%<br />

14.0<br />

10.4<br />

18.9<br />

6.8<br />

11.4<br />

12.0<br />

11.9<br />

10.6<br />

Slide 34 / 55


Cash flow – nine months<br />

Nine months<br />

Net income / loss<br />

Depreciation, amortization and impairment<br />

Other<br />

Payments for restructuring<br />

Operating cash flow before working capital changes<br />

Changes in working capital and provisions<br />

Operating cash flow<br />

Cash flow from investing activities<br />

thereof: property, plant & equipment<br />

thereof: changes in current financial assets<br />

thereof: acquisitions, disposals and other<br />

Cash flow before financing<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>2010</strong><br />

CHF mn<br />

144<br />

206<br />

22<br />

–106<br />

266<br />

99<br />

365<br />

–783<br />

–118<br />

–665<br />

0<br />

-418<br />

Backup slides<br />

2009<br />

CHF mn<br />

–127<br />

203<br />

53<br />

–131<br />

–2<br />

535<br />

533<br />

–75<br />

–96<br />

5<br />

16<br />

458<br />

Slide 35 / 55


Financial result – nine months<br />

Nine months<br />

Interest income<br />

Other financial income<br />

Total financial income<br />

Interest expenses<br />

Other financial expenses<br />

Currency result, net<br />

Total financial expenses<br />

Total financial result<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>2010</strong><br />

CHF mn<br />

6<br />

2<br />

8<br />

–56<br />

–14<br />

–50<br />

–120<br />

2009<br />

CHF mn<br />

5<br />

2<br />

7<br />

–61<br />

–11<br />

–18<br />

–90<br />

– 112 –83<br />

Backup slides<br />

Slide 36 / 55


Sales and EBITDA margins by business<br />

unit – nine months<br />

Nine months <strong>2010</strong><br />

Business Unit / Segment:<br />

BU Industrial & Consumer Specialties<br />

BU Masterbatches<br />

BU Pigments<br />

BU Textile Chemicals<br />

BU Oil & Mining Services<br />

BU Leather Services<br />

Performance Chemicals*<br />

Group total<br />

Sales in % of group<br />

Industrial &<br />

Consumer Specialties<br />

Performance<br />

Chemicals*<br />

20%<br />

Leather Services<br />

21% 18%<br />

4%<br />

8%<br />

12%<br />

Masterbatches<br />

17%<br />

Oil & Mining Services<br />

CHF mn<br />

1 128<br />

981<br />

907<br />

634<br />

438<br />

251<br />

1 081<br />

5 420<br />

Pigments<br />

Textile Chemicals<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Sales<br />

% LC<br />

+14<br />

+21<br />

+17<br />

+11<br />

+5<br />

+30<br />

+11<br />

+14<br />

EBITDA**<br />

EBITDA**<br />

% of Group<br />

23<br />

15<br />

24<br />

7<br />

6<br />

4<br />

21<br />

100<br />

Industrial &<br />

Consumer Specialties<br />

Performance<br />

Chemicals*<br />

EBITDA margin**<br />

% <strong>2010</strong> % 2009<br />

16.5<br />

9.4<br />

12.7<br />

9.4<br />

21.7<br />

6.9<br />

9.6<br />

2.9<br />

12.1<br />

10.9<br />

13.5<br />

1.0<br />

14.8<br />

7.7<br />

13.5<br />

6.7<br />

* includes the four business units Additives, Detergents & Intermediates, Emulsions, Paper Specialties; ** before exceptional items<br />

21%<br />

23%<br />

4% 6%<br />

15%<br />

7%<br />

Leather Services<br />

Oil & Mining Services<br />

Backup slides<br />

24%<br />

Masterbatches<br />

Pigments<br />

Textile Chemicals<br />

Slide 37 / 55


Business Unit sales and EBIT before<br />

exceptional items – nine months (1)<br />

Industrial & Consumer Specialties Masterbatches<br />

Sales in CHF mn<br />

9M<br />

<strong>2010</strong><br />

1 128<br />

Pigments<br />

Change<br />

(LC)<br />

Sales in CHF mn<br />

9M<br />

<strong>2010</strong><br />

907<br />

9M<br />

2009<br />

EBIT before exc. in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

9M<br />

2009<br />

158<br />

69<br />

102<br />

+14% 1 052<br />

+148% 981 +21% 842<br />

14.0%<br />

6.6%<br />

10.4%<br />

+97%<br />

Change<br />

(LC)<br />

9M<br />

2009<br />

EBIT before exc. in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

171<br />

+17% 797<br />

+530%<br />

18.9%<br />

9M<br />

2009<br />

28<br />

3.5%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Sales in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

Textile Chemicals<br />

Sales in CHF mn<br />

9M<br />

<strong>2010</strong><br />

634<br />

Change<br />

(LC)<br />

9M<br />

2009<br />

9M<br />

2009<br />

EBIT before exc. in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Backup slides<br />

Change<br />

(LC)<br />

43<br />

+11% 578<br />

–<br />

6.8%<br />

9M<br />

2009<br />

54<br />

6.4%<br />

EBIT before exc. in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

9M<br />

2009<br />

0<br />

0.0%<br />

Slide 38 / 55


Business Unit sales and EBIT before<br />

exceptional items – nine months (2)<br />

Oil & Mining Services Leather Services<br />

Sales in CHF mn<br />

9M<br />

<strong>2010</strong><br />

438<br />

Change<br />

(LC)<br />

9M<br />

2009<br />

EBIT before exc. in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

9M<br />

2009<br />

50<br />

43<br />

30<br />

+5% 423<br />

+17% 251 +30% 197<br />

11.4%<br />

10.2%<br />

12.0%<br />

–<br />

Performance Chemicals*<br />

Sales in CHF mn<br />

9M<br />

<strong>2010</strong><br />

1 081<br />

Change<br />

(LC)<br />

9M<br />

2009<br />

EBIT before exc. in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

129<br />

+11% 1 015<br />

+227%<br />

11.9%<br />

9M<br />

2009<br />

42<br />

4.1%<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Sales in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Change<br />

(LC)<br />

9M<br />

2009<br />

EBIT before exc. in CHF mn<br />

9M<br />

<strong>2010</strong><br />

Backup slides<br />

Change<br />

(LC)<br />

9M<br />

2009<br />

–2<br />

–1.0%<br />

* the Performance Chemicals segment includes the business units:<br />

- Additives<br />

- Detergents & Intermediates<br />

- Emulsions<br />

- Paper Specialties<br />

Slide 39 / 55


Key financials – third quarter<br />

Third quarter<br />

Sales<br />

Local currency growth (LC)<br />

Net income<br />

- Organic growth rate*<br />

- Acquisitions/Divestments<br />

Currencies<br />

Gross profit**<br />

EBITDA before exceptionals<br />

EBITDA<br />

Operating income before exceptionals<br />

Operating income<br />

Operating cash flow<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

CHF mn<br />

1 709<br />

8%<br />

8%<br />

0%<br />

–7%<br />

477<br />

232<br />

206<br />

182<br />

137<br />

109<br />

173<br />

<strong>2010</strong><br />

% of sales<br />

100%<br />

27.9%<br />

13.6%<br />

12.1%<br />

10.6%<br />

8.0%<br />

6.4%<br />

CHF mn<br />

1 691<br />

428<br />

163<br />

25<br />

193<br />

2009<br />

% of sales<br />

* organic growth: volume and price effects excluding the impact of changes in foreign currency exchange rates and acquisitions/divestments<br />

** gross profit incl. freight costs as of first quarter <strong>2010</strong>. Reported gross profit in third quarter 2009 was CHF 509 million, gross margin 30.1%<br />

132<br />

107<br />

71<br />

Backup slides<br />

100%<br />

25.3%<br />

9.6%<br />

7.8%<br />

6.3%<br />

4.2%<br />

1.5%<br />

Slide 40 / 55


Cash flow – third quarter<br />

Third quarter<br />

Net income<br />

Depreciation, amortization and impairment<br />

Other<br />

Payments for restructuring<br />

Operating cash flow before working capital changes<br />

Changes in working capital and provisions<br />

Operating cash flow<br />

Cash flow from investing activities<br />

thereof: property, plant & equipment<br />

thereof: changes in current financial assets<br />

thereof: acquisitions, disposals and other<br />

Cash flow before financing<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>2010</strong><br />

CHF mn<br />

109<br />

69<br />

–25<br />

–37<br />

116<br />

57<br />

173<br />

–339<br />

–55<br />

–282<br />

–2<br />

–166<br />

Backup slides<br />

2009<br />

CHF mn<br />

25<br />

61<br />

37<br />

–45<br />

78<br />

115<br />

193<br />

8<br />

–26<br />

2<br />

32<br />

201<br />

Slide 41 / 55


Financial result – third quarter<br />

Third quarter<br />

Interest income<br />

Other financial income<br />

Total financial income<br />

Interest expenses<br />

Other financial expenses<br />

Currency result, net<br />

Total financial expenses<br />

Total financial result<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

<strong>2010</strong><br />

CHF mn<br />

2<br />

0<br />

2<br />

–19<br />

–1<br />

–9<br />

–29<br />

2009<br />

CHF mn<br />

1<br />

1<br />

2<br />

–21<br />

–5<br />

–4<br />

–30<br />

–27 –28<br />

Backup slides<br />

Slide 42 / 55


Sales and EBITDA margins by business<br />

unit – third quarter<br />

Third quarter <strong>2010</strong><br />

Business Unit / Segment:<br />

BU Industrial & Consumer Specialties<br />

BU Masterbatches<br />

BU Pigments<br />

BU Textile Chemicals<br />

BU Oil & Mining Services<br />

BU Leather Services<br />

Performance Chemicals*<br />

Group total<br />

Sales in % of group Masterbatches<br />

Industrial &<br />

Consumer Specialties<br />

Performance<br />

Chemicals*<br />

20%<br />

20%<br />

Leather Services<br />

4%<br />

8%<br />

18%<br />

12%<br />

18%<br />

Oil & Mining Services<br />

CHF mn<br />

341<br />

315<br />

301<br />

199<br />

142<br />

76<br />

335<br />

1 709<br />

Pigments<br />

Textile Chemicals<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Sales<br />

% LC<br />

+9<br />

+11<br />

+11<br />

+3<br />

+10<br />

+5<br />

+6<br />

+8<br />

EBITDA**<br />

EBITDA**<br />

% of Group<br />

22<br />

16<br />

26<br />

8<br />

6<br />

4<br />

18<br />

100<br />

Industrial &<br />

Consumer Specialties<br />

Performance<br />

Chemicals*<br />

Leather Services<br />

EBITDA margin**<br />

% <strong>2010</strong> % 2009<br />

15.8<br />

10.6<br />

12.4<br />

11.8<br />

21.9<br />

13.0<br />

9.5<br />

7.0<br />

11.3<br />

12.5<br />

13.2<br />

9.3<br />

13.1<br />

11.1<br />

13.6<br />

9.6<br />

Oil & Mining Services<br />

* includes the four business units Additives, Detergents & Intermediates, Emulsions, Paper Specialties; **before exceptional items<br />

22%<br />

18%<br />

16%<br />

4% 6%<br />

Backup slides<br />

8%<br />

Masterbatches<br />

26%<br />

Pigments<br />

Textile Chemicals<br />

Slide 43 / 55


Quarterly Business Unit sales and EBIT<br />

before exceptional items 2009/<strong>2010</strong> (1)<br />

Industrial & Consumer Specialties<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

Sales<br />

380<br />

- margin<br />

EBIT bef. exceptionals<br />

- margin<br />

24<br />

324<br />

18<br />

EBITDA bef. exceptionals<br />

348<br />

Quarterly figures* 2009 & <strong>2010</strong> – in CHF mn<br />

27<br />

373<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

46<br />

Q1<br />

380<br />

34<br />

8.9%<br />

24<br />

6.3%<br />

420<br />

67<br />

Q2<br />

324<br />

28<br />

8.6%<br />

18<br />

5.6%<br />

367<br />

<strong>Q3</strong><br />

348<br />

37<br />

10.6%<br />

27<br />

7.8%<br />

341<br />

45 46<br />

Q1 2009 Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

Q4<br />

373<br />

57<br />

15.3%<br />

46<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

12.3%<br />

FY/09<br />

1 425<br />

156<br />

10.9%<br />

115<br />

8.1%<br />

Sales EBIT bef.<br />

exceptionals<br />

Q1/10<br />

420<br />

76<br />

18.1%<br />

67<br />

16.0%<br />

Backup slides<br />

Q2/10<br />

367<br />

56<br />

15.3%<br />

45<br />

12.3%<br />

EBIT bef.<br />

exceptionals – margin<br />

<strong>Q3</strong>/10<br />

341<br />

54<br />

15.8%<br />

46<br />

13.5%<br />

* unaudited<br />

Slide 44 / 55


Quarterly Business Unit sales and EBIT<br />

before exceptional items 2009/<strong>2010</strong> (2)<br />

Masterbatches<br />

400<br />

300<br />

200<br />

100<br />

0<br />

Sales<br />

260<br />

- margin<br />

EBIT bef. exceptionals<br />

- margin<br />

6<br />

277<br />

20<br />

EBITDA bef. exceptionals<br />

305<br />

Quarterly figures* 2009 & <strong>2010</strong> – in CHF mn<br />

28<br />

280<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

18<br />

Q1 2009 Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

Q1<br />

260<br />

15<br />

5.8%<br />

6<br />

2.3%<br />

321<br />

32<br />

Q2<br />

277<br />

28<br />

10.1%<br />

20<br />

7.2%<br />

345<br />

38<br />

<strong>Q3</strong><br />

305<br />

36<br />

11.8%<br />

28<br />

9.2%<br />

315<br />

32<br />

Q4<br />

280<br />

26<br />

9.3%<br />

18<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

6.4%<br />

FY/09<br />

1 122<br />

105<br />

9.4%<br />

72<br />

6.4%<br />

Sales EBIT bef.<br />

exceptionals<br />

Q1/10<br />

321<br />

40<br />

12.5%<br />

32<br />

10.0%<br />

Backup slides<br />

Q2/10<br />

345<br />

46<br />

13.3%<br />

38<br />

11.0%<br />

EBIT bef.<br />

exceptionals – margin<br />

<strong>Q3</strong>/10<br />

315<br />

39<br />

12.4%<br />

32<br />

10.2%<br />

* unaudited<br />

Slide 45 / 55


Quarterly Business Unit sales and EBIT<br />

before exceptional items 2009/<strong>2010</strong> (3)<br />

Pigments<br />

400<br />

300<br />

200<br />

100<br />

0<br />

Sales<br />

240<br />

EBITDA bef. exceptionals<br />

- margin<br />

EBIT bef. exceptionals<br />

- margin<br />

273 284 275 281<br />

14<br />

Quarterly figures* 2009 & <strong>2010</strong> – in CHF mn<br />

28<br />

–14<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

20<br />

Q1 2009<br />

-14<br />

Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

Q1<br />

240<br />

–5<br />

–2.1%<br />

–5.8%<br />

45<br />

Q2<br />

273<br />

23<br />

8.4%<br />

14<br />

5.1%<br />

325<br />

68<br />

<strong>Q3</strong><br />

284<br />

37<br />

13.0%<br />

28<br />

9.9%<br />

301<br />

58<br />

Q4<br />

275<br />

28<br />

10.2%<br />

20<br />

80<br />

60<br />

40<br />

20<br />

0<br />

-20<br />

7.3%<br />

FY/09<br />

1 072<br />

83<br />

7.7%<br />

48<br />

4.5%<br />

Sales EBIT bef.<br />

exceptionals<br />

Q1/10<br />

281<br />

54<br />

19.2%<br />

45<br />

16.0%<br />

Backup slides<br />

Q2/10<br />

325<br />

77<br />

23.7%<br />

68<br />

20.9%<br />

EBIT bef.<br />

exceptionals – margin<br />

<strong>Q3</strong>/10<br />

301<br />

66<br />

21.9%<br />

58<br />

19.3%<br />

* unaudited<br />

Slide 46 / 55


Quarterly Business Unit sales and EBIT<br />

before exceptional items 2009/<strong>2010</strong> (4)<br />

Textile Chemicals<br />

250<br />

200<br />

150<br />

100<br />

50<br />

0<br />

Sales<br />

180<br />

- margin<br />

EBIT bef. exceptionals<br />

- margin<br />

-9<br />

EBITDA bef. exceptionals<br />

198 200 199 204<br />

1<br />

Quarterly figures* 2009 & <strong>2010</strong> – in CHF mn<br />

8<br />

Q1 2009 Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

–3<br />

–9<br />

0<br />

Q1<br />

180<br />

–1.7%<br />

–5.0%<br />

9<br />

Q2<br />

198<br />

6<br />

3.0%<br />

1<br />

0.5%<br />

231<br />

22<br />

<strong>Q3</strong><br />

200<br />

14<br />

7.0%<br />

8<br />

4.0%<br />

199<br />

12<br />

Q4<br />

199<br />

6<br />

3.0%<br />

0<br />

30<br />

20<br />

10<br />

0<br />

-10<br />

0.0%<br />

FY/09<br />

777<br />

23<br />

3.0%<br />

0<br />

0.0%<br />

Sales EBIT bef.<br />

exceptionals<br />

Q1/10<br />

204<br />

15<br />

7.4%<br />

9<br />

4.4%<br />

Backup slides<br />

Q2/10<br />

231<br />

27<br />

11.7%<br />

22<br />

9.5%<br />

EBIT bef.<br />

exceptionals – margin<br />

<strong>Q3</strong>/10<br />

199<br />

19<br />

9.5%<br />

12<br />

6.0%<br />

* unaudited<br />

Slide 47 / 55


Quarterly Business Unit sales and EBIT<br />

before exceptional items 2009/<strong>2010</strong> (5)<br />

Oil & Mining Services<br />

160<br />

120<br />

80<br />

40<br />

0<br />

Sales<br />

156<br />

- margin<br />

EBIT bef. exceptionals<br />

- margin<br />

131<br />

EBITDA bef. exceptionals<br />

136<br />

17 16<br />

10<br />

Quarterly figures* 2009 & <strong>2010</strong> – in CHF mn<br />

155 148 148 142<br />

22 21<br />

Q1 2009 Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Q1<br />

156<br />

18<br />

11.5%<br />

17<br />

10.9%<br />

Q2<br />

131<br />

11<br />

8.4%<br />

10<br />

7.6%<br />

13<br />

<strong>Q3</strong><br />

136<br />

17<br />

12.5%<br />

16<br />

11.8%<br />

16<br />

Q4<br />

155<br />

24<br />

15.5%<br />

22<br />

30<br />

20<br />

10<br />

0<br />

14.2%<br />

FY/09<br />

578<br />

70<br />

12.1%<br />

65<br />

11.2%<br />

Sales EBIT bef.<br />

exceptionals<br />

Q1/10<br />

148<br />

22<br />

14.9%<br />

21<br />

14.2%<br />

Backup slides<br />

Q2/10<br />

148<br />

15<br />

10.1%<br />

13<br />

8.8%<br />

EBIT bef.<br />

exceptionals – margin<br />

<strong>Q3</strong>/10<br />

142<br />

16<br />

11.3%<br />

16<br />

11.3%<br />

* unaudited<br />

Slide 48 / 55


Quarterly Business Unit sales and EBIT<br />

before exceptional items 2009/<strong>2010</strong> (6)<br />

Leather Services<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

Sales<br />

51<br />

- margin<br />

EBIT bef. exceptionals<br />

- margin<br />

-9<br />

71<br />

EBITDA bef. exceptionals<br />

1<br />

Quarterly figures* 2009 & <strong>2010</strong> – in CHF mn<br />

75<br />

6<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

82<br />

7<br />

Q1 2009 Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

Q1<br />

51<br />

–8<br />

–15.7%<br />

–9<br />

–17.6%<br />

84<br />

10<br />

Q2<br />

71<br />

3<br />

4.2%<br />

1<br />

1.4%<br />

91<br />

11<br />

<strong>Q3</strong><br />

75<br />

7<br />

9.3%<br />

6<br />

8.0%<br />

76<br />

9<br />

Q4<br />

82<br />

8<br />

9.8%<br />

7<br />

15<br />

10<br />

5<br />

0<br />

-5<br />

8.5%<br />

FY/09<br />

279<br />

10<br />

3.6%<br />

5<br />

1.8%<br />

Sales EBIT bef.<br />

exceptionals<br />

Q1/10<br />

84<br />

11<br />

13.1%<br />

10<br />

11.9%<br />

Backup slides<br />

Q2/10<br />

91<br />

13<br />

14.3%<br />

11<br />

12.1%<br />

EBIT bef.<br />

exceptionals – margin<br />

<strong>Q3</strong>/10<br />

76<br />

10<br />

13.2%<br />

9<br />

11.8%<br />

* unaudited<br />

Slide 49 / 55


Quarterly Business Unit sales and EBIT<br />

before exceptional items 2009/<strong>2010</strong> (7)<br />

Performance Chemicals (including Additives, Detergents & Intermediates, Emulsions, Paper Specialties)<br />

400<br />

300<br />

200<br />

100<br />

0<br />

Sales<br />

- margin<br />

EBIT bef. exceptionals<br />

- margin<br />

337 335 343 346 359<br />

26<br />

EBITDA bef. exceptionals<br />

26 23<br />

Q1 2009<br />

-10<br />

Q2 2009 <strong>Q3</strong> 2009 Q4 2009 Q1 <strong>2010</strong> Q2 <strong>2010</strong> <strong>Q3</strong> <strong>2010</strong><br />

Quarterly figures* 2009 & <strong>2010</strong> – in CHF mn<br />

–10<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Q1<br />

337<br />

2<br />

0.6%<br />

–3.0%<br />

41<br />

Q2<br />

335<br />

38<br />

11.3%<br />

26<br />

7.8%<br />

387<br />

54<br />

<strong>Q3</strong><br />

343<br />

38<br />

11.1%<br />

26<br />

7.6%<br />

335<br />

34<br />

Q4<br />

346<br />

35<br />

10.1%<br />

23<br />

60<br />

40<br />

20<br />

0<br />

-20<br />

6.6%<br />

FY/09<br />

1 361<br />

113<br />

8.3%<br />

65<br />

4.8%<br />

Sales EBIT bef.<br />

exceptionals<br />

Q1/10<br />

359<br />

52<br />

14.5%<br />

41<br />

11.4%<br />

Backup slides<br />

Q2/10<br />

387<br />

64<br />

16.5%<br />

54<br />

14.0%<br />

EBIT bef.<br />

exceptionals – margin<br />

<strong>Q3</strong>/10<br />

335<br />

44<br />

13.1%<br />

34<br />

10.1%<br />

* unaudited<br />

Slide 50 / 55


Debt maturity profile as of 30 Sept <strong>2010</strong><br />

Liquidity headroom<br />

Open undrawn<br />

credit facilities<br />

at local affiliates<br />

Open undrawn<br />

credit facilities<br />

in Switzerland<br />

Cash*<br />

2500<br />

2000<br />

1500<br />

1000<br />

500<br />

in CHF mn<br />

* incl. short-term deposits >94d<br />

0<br />

800<br />

200<br />

1 272<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Maturities of financial debt<br />

800<br />

700<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

0<br />

Local rollover loans for<br />

net working capital<br />

financing<br />

33<br />

249<br />

783<br />

269<br />

Backup slides<br />

Bonds & private placements<br />

Uncommitted & other loans<br />

105<br />

133<br />

0<br />

2<br />

<strong>2010</strong> 2011 2012 2013 2014 2015 2016<br />

Slide 51 / 55


Sales and cost structure – nine months<br />

Global sales distribution in % Global cost distribution in %<br />

EUR<br />

43<br />

CHF<br />

0<br />

Emerging<br />

markets<br />

28<br />

GBP<br />

2<br />

USD<br />

23<br />

JPY<br />

4<br />

These distributions represent an approximation to total cash in- and outflows and are closely linked to transaction exposures<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

CHF<br />

7<br />

EUR<br />

51<br />

Emerging<br />

markets<br />

17<br />

Backup slides<br />

JPY<br />

2<br />

USD<br />

22<br />

GBP<br />

1<br />

Slide 52 / 55


Top 20 products in percentage of total<br />

raw material costs<br />

Ranking Product<br />

1 Ethylene<br />

2 Polyethylene<br />

3 Ethylene oxide<br />

4 Acetic anhydride<br />

5 Propyleneglycol<br />

6 Sodium hydroxide<br />

7 N-Paraffin C14-C17<br />

8 Cetyl/dodecyl alcohol<br />

9 Vinyl acetate<br />

10 Titanium dioxide<br />

11 Propylene oxide<br />

12 Ethylenediamine<br />

13 29H,31H-Phthalocyanine copper salt<br />

14 Butyl acrylate<br />

15 Tallow fatty acid<br />

16 Amsonic acid (DAST)<br />

17 Acetic acid<br />

18 Acetaldehyde<br />

19 3,3'-Dichlorobenzidine dihydrochloride<br />

20 Phosphorus white<br />

Over 15 300 products in total<br />

Approx. 190 products account for 50% of raw material costs<br />

Approx. 3 000 products account for 90% of raw material costs<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

15%<br />

16%<br />

Backup slides<br />

69%<br />

Top 5 Top 6 - 20 Others<br />

Slide 53 / 55


Raw material classification and dependence<br />

on oil price<br />

Dependence on oil price Product groups<br />

Independent<br />

35%<br />

Indirectly dependent<br />

via feedstock<br />

(e.g. benzene, phenol)<br />

50%<br />

15%<br />

Directly<br />

dependent<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Specialty chemicals<br />

incl. aromatics and<br />

oleochemicals<br />

Petrochemicals<br />

40%<br />

40%<br />

Backup slides<br />

20%<br />

Base<br />

chemicals<br />

Slide 54 / 55


Disclaimer<br />

This presentation contains certain statements that are neither reported financial results nor other<br />

historical information. This presentation also includes forward-looking statements.<br />

Because these forward-looking statements are subject to risks and uncertainties, actual future<br />

results may differ materially from those expressed in or implied by the statements. Many of these<br />

risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate<br />

precisely, such as future market conditions, currency fluctuations, the behavior of other market<br />

participants, the actions of governmental regulators and other risk factors such as: the timing and<br />

strength of new product offerings; pricing strategies of competitors; the Company's ability to<br />

continue to receive adequate products from its vendors on acceptable terms, or at all, and to<br />

continue to obtain sufficient financing to meet its liquidity needs; and changes in the political,<br />

social and regulatory framework in which the Company operates or in economic or technological<br />

trends or conditions, including currency fluctuations, inflation and consumer confidence, on a<br />

global, regional or national basis.<br />

Readers are cautioned not to place undue reliance on these forward-looking statements, which<br />

speak only as of the date of this document. Clariant does not undertake any obligation to publicly<br />

release any revisions to these forward-looking statements to reflect events or circumstances<br />

after the date of these materials.<br />

9M <strong>2010</strong> / <strong>Q3</strong> <strong>2010</strong>, <strong>Analyst</strong>s <strong>Presentation</strong>, 3 November <strong>2010</strong> (Copyright Clariant. All rights reserved.)<br />

Slide 55 / 55

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!